256 related articles for article (PubMed ID: 15669671)
1. Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review.
Brumm VL; Azen C; Moats RA; Stern AM; Broomand C; Nelson MD; Koch R
J Inherit Metab Dis; 2004; 27(5):549-66. PubMed ID: 15669671
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive functioning in adults with phenylketonuria: Report of a 10-year follow-up.
Feldmann R; Osterloh J; Onon S; Fromm J; Rutsch F; Weglage J
Mol Genet Metab; 2019 Mar; 126(3):246-249. PubMed ID: 30598390
[TBL] [Abstract][Full Text] [Related]
4. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
Anastasoaie V; Kurzius L; Forbes P; Waisbren S
Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
[TBL] [Abstract][Full Text] [Related]
5. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
6. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
[TBL] [Abstract][Full Text] [Related]
7. Executive function impairment in early-treated PKU subjects with normal mental development.
Leuzzi V; Pansini M; Sechi E; Chiarotti F; Carducci C; Levi G; Antonozzi I
J Inherit Metab Dis; 2004; 27(2):115-25. PubMed ID: 15159642
[TBL] [Abstract][Full Text] [Related]
8. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
[TBL] [Abstract][Full Text] [Related]
9. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain phenylalanine relationships in persons with phenylketonuria.
Koch R; Moats R; Guttler F; Guldberg P; Nelson M
Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780
[TBL] [Abstract][Full Text] [Related]
11. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I
J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study.
Nardecchia F; Manti F; Chiarotti F; Carducci C; Carducci C; Leuzzi V
Mol Genet Metab; 2015; 115(2-3):84-90. PubMed ID: 25952249
[TBL] [Abstract][Full Text] [Related]
14. Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study.
Jahja R; van Spronsen FJ; de Sonneville LMJ; van der Meere JJ; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; Huijbregts SCJ
J Inherit Metab Dis; 2016 May; 39(3):355-362. PubMed ID: 26914933
[TBL] [Abstract][Full Text] [Related]
15. Tackling frontal lobe-related functions in PKU through functional brain imaging: a Stroop task in adult patients.
Sundermann B; Pfleiderer B; Möller HE; Schwindt W; Weglage J; Lepsien J; Feldmann R
J Inherit Metab Dis; 2011 Jun; 34(3):711-21. PubMed ID: 21491106
[TBL] [Abstract][Full Text] [Related]
16. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
[TBL] [Abstract][Full Text] [Related]
17. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.
Moyle JJ; Fox AM; Arthur M; Bynevelt M; Burnett JR
Neuropsychol Rev; 2007 Jun; 17(2):91-101. PubMed ID: 17410469
[TBL] [Abstract][Full Text] [Related]
19. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Diamond A; Prevor MB; Callender G; Druin DP
Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
[TBL] [Abstract][Full Text] [Related]
20. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
Romani C; Palermo L; MacDonald A; Limback E; Hall SK; Geberhiwot T
Neuropsychology; 2017 Mar; 31(3):242-254. PubMed ID: 28240926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
